Markers of oxidative damage lipids and DNA in men with type 1 diabetes mellitus and different levels of albuminuria

BACKGROUND: Diabetic nephropathy is a specific kidney damage that affects up to 40% of type 1 diabetes mellitus patients. There is still insufficient knowledge about oxidative stress at the different levels of albuminuria.

AIM: To assess the indicators of oxidative damage to lipids, DNA and antioxidant defense in men with type 1 diabetes mellitus and albuminuria different levels.

MATERIALS AND METHODS: The study was conducted during 2018–2019. The main group included 56 men of reproductive age with type 1 diabetes mellitus (T1DM) divided into 2 groups: 24 patients with albuminuria level A1 (group A1) and 32 patients with albuminuria level A2 (group A2). The control group consisted of 28 healthy men. The oxidative stress indicators content, as well as the activity of antioxidant defense system various links was evaluated. Spectrophotometric, fluorimetric and enzyme immunoassay methods were used.

RESULTS: In patients of the A1 group there were higher values of the median of primary — conjugated dienes, secondary — ketodienes and conjugated trienes, final — Schiff bases products and 8-hydroxy-2’-deoxyguanosine in comparison with the control. Similar changes in patients of the A2 group were found. Intergroup differences related to increased median values of TBARs and 8-hydroxy-2’-deoxyguanosine in patients of the A2 group compared with A1 group. The activity of the antioxidant defense system in A1 group relative to the control by increased values of the glutathione peroxidase, reduced glutathione, oxidized glutathione median, and retinol was characterized. A2 group had higher values of glutathione peroxidase, reduced glutathione and oxidized glutathione medians in comparison with controls. Correlation analysis in A1 group showed the relationships between the duration of the disease and the products of lipid peroxidation, glycated hemoglobin with 8-hydroxy-2’-deoxyguanosine. In A2 group, there was a relationship between the albumin/creatinine ratio and the duration of the disease, glomerular filtration rate and creatinine level.

CONCLUSION: In men with T1DM, regardless of the albuminuria level, there are higher values of the oxidative damage lipids and DNA parameters, as well as the presence of close relationships between these parameters and the duration of the disease, which can be used to develop potential strategies for the prevention and early therapy of diabetic nephropathy.

1. International Diabetes Atlas, 2019.

2. Dedov II, Shestakova MV, Vikulova OK, et al. Diabetes mellitus in the Russian Federation: prevalence, morbidity, mortality, parameters of carbohydrate metabolism and the structure of hypoglycemic therapy according to the Federal Register of Diabetes Mellitus, status 2017. Diabetes mellitus. 2018;21(3):144-159. (In Russ.). doi: https://doi.org/10.14341/DM9686

3. Dedov II, Shestakova MV, Mayorov AYu, et al. Type 1 diabetes mellitus in adults // Diabetes mellitus. 2020;23(S1). (In Russ.). doi: https://doi.org/10.14341/DM23S1

4. Paul S, Ali A, Katare R. Molecular complexities underlying the vascular complications of diabetes mellitus – A comprehensive review. J Diabetes Complications. 2020;34(8):107613. doi: https://doi.org/10.1016/j.jdiacomp.2020.107613

5. Selby NM, Taal MW. An updated overview of diabetic nephropathy: Diagnosis, prognosis, treatment goals and latest guidelines. Diabetes, Obesity and Metabolism. 2020;22:3-15. doi: https://doi.org/10.1111/dom.14007

6. Sagoo MK, Gnudi L. Diabetic nephropathy: an overview. Diabetic Nephropathy. 2020:3-7. doi: https://doi.org/10.1007/978-1-4939-9841-8_1

7. Shchukina AA, Bobkova IN, Shestakova MV, et al. Urinary excretion of markers of podocyte damage in patients with diabetes. Therapeutic archive. 2015;87(10):62-66. (In Russ.). doi: https://doi.org/10.17116/terarkh2015871062-66

8. Shestakova MV, Shamkhalova MSh, Yarek-Martynova IYa, et al. Diabetes mellitus and chronic kidney disease: achievements, unresolved problems and treatment prospects. Diabetes mellitus. 2011;14(1):81-88. (In Russ.). doi: https://doi.org/10.14341/2072-0351-6254

9. Shestakova MV. Diabetes mellitus and chronic kidney disease: possibilities of prediction, early diagnosis and nephroprotection in the XXI century. Therapeutic archive. 2016;88(6):84-88. (In Russ.). doi: https://doi.org/10.17116/terarkh201688684-88

10. Yang S, Han Y, Liu J, et al. Mitochondria: a novel therapeutic target in diabetic nephropathy. Current medicinal chemistry. 2017;24(29):3185-3202. doi: https://doi.org/10.2174/0929867324666170509121003

11. Saxena S, Mathur A, Kakkar P. Critical role of mitochondrial dysfunction and impaired mitophagy in diabetic nephropathy. Journal of cellular physiology. 2019;234(11):19223-19236. doi: https://doi.org/10.1002/jcp.28712

12. Kolesnikova LI, Darenskaya MA, Kolesnikov SI. Free radical oxidation: a pathophysiologist’s view. Bulletin of Siberian Medicine. 2017;16(4):16-29. (In Russ.). doi: https://doi.org/10.20538/1682-0363-2017-4-16–29

13. Yaribeygi H, Sathyapalan T, Atkin SL, Sahebkar A. Molecular Mechanisms Linking Oxidative Stress and Diabetes Mellitus. Oxid Med Cell Longev. 2020;2020:1-13. doi: https://doi.org/10.1155/2020/8609213

14. Lassén E, Daehn IS. Molecular Mechanisms in Early Diabetic Kidney Disease: Glomerular Endothelial Cell Dysfunction. Int J Mol Sci. 2020;21(24):9456. doi: https://doi.org/10.3390/ijms21249456

15. Vodošek Hojs N, Bevc S, Ekart R, et al. Oxidative stress markers in chronic kidney disease with emphasis on diabetic nephropathy. Antioxidants. 2020;9(10):925. doi: https://doi.org/10.3390/antiox9100925

16. Turpin C, Catan A, Guerin-Dubourg A, et al. Enhanced oxidative stress and damage in glycated erythrocytes. PloS One. 2020;15(7):e0235335. doi: https://doi.org/10.1371/journal.pone.0235335

17. Larina II, Severina AS, Shamkhalova M Sh, et al. Complications of chronic kidney disease in patients with type 1 diabetes mellitus after combined kidney and pancreas transplantation — the potential role of oxidative stress and end glycation products. Diabetes mellitus. 2019;22(5):405-416. (In Russ.). doi: https://doi.org/10.14341/DM10312

18. Chernikov AA, Severina AS, Shamkhalova MSh, Shestakova MV. The role of metabolic memory mechanisms in the development and progression of vascular complications of diabetes mellitus. Diabetes mellitus. 2017;20(2):126-134. (In Russ.). doi: https://doi.org/10.14341/7674

19. Grigoryan OR, Andreeva EN, Dedov II. Personalized strategies in reproductive medicine for patients with endocrine disorders. // Therapeutic archive. 2018;90(4):81-84. (In Russ.). doi: https://doi.org/10.26442/terarkh201890481-84

20. Dedov II, Shestakova MV, Mayorov AYu, et al. Standards of specialized diabetes care. Diabetes Mellitus. 2019;22(S1):1-144 (In Russ.). doi: https://doi.org/10.14341/DM221S1

21. Volchegorskiy IA, Nalimov AG, Yarovinskiy BG, et al. Comparison of different approaches to the determination of lipid peroxidation products in heptane-isopropanol extracts of blood. Questions of medicinal chemistry. 1989;35(1):127-131. (In Russ.).

22. Gavrilov VB, Gavrilova AR, Mazhul LM. Analysis of methods for determining the products of lipid peroxidation in blood serum by the test with thiobarbituric acid. Questions of medicinal chemistry. 1987;33(1):118-122. (In Russ.).

23. ЧChernyauskene RCh, Varskevichene ZZ, Grybauskas PS. Simultaneous determination of the concentrations of vitamins E and A in blood serum. Laboratornoe delo. 1984;6:362-365. (In Russ.).

24. Hisin PJ, Hilf R. Fluorоmetric method for determination of oxidized and reduced glutathione in tissues. Anal. Biochem. 1976;74:214-226.

25. Kolesnikova LI, Shemyakina NA, Namokonov EV, et al. Some parameters of carbonyl and oxidative stress in patients with type 2 diabetes mellitus and macroangiopathy of the lower extremities. Diabetes Technol. Therapeutics. 2019:21(S1):46.

26. Kolesnikova LI, Vlasov BY, Kolesnikov SI, et al. Intensity of oxidative stress in Mongoloid and Caucasian patients with type 1 diabetes mellitus. Bull. Exp. Biol. 2016;161(6):767-769. doi: https://doi.org/10.1007/s10517-016-3505-0

27. Victor P, Umapathy D, George L, et al. Crosstalk between endoplasmic reticulum stress and oxidative stress in the progression of diabetic nephropathy. Cell Stress and Chaperones. 2021;26(2):311-321. doi: https://doi.org/10.1007/s12192-020-01176-z

28. Charlton A, Garzarella J, Jandeleit-Dahm KA, et al. Oxidative stress and inflammation in renal and cardiovascular complications of diabetes. Biology. 2021;10(1):18. doi: https://doi.org/10.3390/biology10010018

29. Sies H, Jones DP. Reactive oxygen species (ROS) as pleiotropic physiological signalling agents. Nat. Rev. Mol. Cell Biol. 2020;21(7):363-383. doi: https://doi.org/10.1038/s41580-020-0230-3

30. Darenskaya MA, Kolesnikova LI, Kolesnikov SI. Oxidative stress: pathogenetic role in the development of diabetes mellitus and its complications, therapeutic approaches to correction. Bulletin of Experimental Biology and Medicine. 2021;171(2):136-149. (In Russ.). doi: https://doi.org/10.47056/0365-9615-2021-171-2-136-149

31. Sanchez M, Roussel R, Hadjadj S, et al. Plasma concentrations of 8-hydroxy-2′-deoxyguanosine and risk of kidney disease and death in individuals with type 1 diabetes. Diabetologia. 2018;61:977-984. doi: https://doi.org/10.1007/s00125-017-4510-1

32. Qi H, Casalena G, Shi S, et al. Glomerular endothelial mitochondrial dysfunction is essential and characteristic of diabetic kidney disease susceptibility. Diabetes. 2017;66:763-778. doi: https://doi.org/10.2337/db16-0695

33. Chistyakova OV, Sukhov IB, Shpakov AO. The role of oxidative stress and antioxidant enzymes in the development of diabetes mellitus. I.M. Sechenov Physiological Journal. 2017;103(9):987-1003. (In Russ.).

34. Marí M, de Gregorio E, de Dios C, et al. Mitochondrial glutathione: recent insights and role in disease. Antioxidants. 2021;9(10):909. doi: https://doi.org/10.3390/antiox9100909

35. Silvagno F, Vernone A, Pescarmona GP. The role of glutathione in protecting against the severe inflammatory response triggered by COVID-19. Antioxidants. 2020;9(7):624. doi: https://doi.org/10.3390/antiox9070624

36. Bebu I, Braffett BH, Schade D, et al. An observational study of the equivalence of age and duration of diabetes to glycemic control relative to the risk of complications in the combined cohorts of the DCCT/EDIC study. Diabetes care. 2020;43(10):2478-2484. doi: https://doi.org/10.2337/dc20-0226